PubMed HealthSearch

Biomedical subjects

M F Gemon

Publications and source records attributed to M F Gemon.

12 recordsLinked to original sources

[Leukemic meningitis].

Explore the source record for details and available documents.

Central Nervous System Diseases

Treatment of acute myeloblastic leukaemia with RP 22050.

Fourty-four patients with acute myeloblastic leukaemia were treated with RP 22050, a new, semisynthetic derivative of daunorubicin. Complete remissions were achieved in 20 patients (45%). The median dose given was 23 mg/kg. The toxicity of RP 22050 is mainly haematological. Resistance rather than death in aplasia seemed to be the cause of failure of therapy.

Adult